Core Viewpoint - Sino Medical announced a total operating revenue of 525.41 million yuan for the fiscal year 2025, representing a year-on-year growth of 14.53% [1] - The net profit attributable to the parent company reached 47.29 million yuan, showing a significant year-on-year increase of 3,057.05% [1] - The non-recurring net profit was reported at 33.96 million yuan, reflecting a year-on-year growth of 293.82% [1] Financial Performance - The substantial increase in net profit is attributed to continuous revenue growth, a decrease in costs, and a reduction in certain expenses, along with a low base from the previous year [1] - As of the end of the reporting period, total assets amounted to 1.35 billion yuan, which is a 3.78% increase compared to the end of the previous year [1] - The equity attributable to the parent company was 927.64 million yuan, marking a growth of 7.01% [1] Data Notes - The figures provided are preliminary estimates and may differ from the final annual report [1]
赛诺医疗:2025年营收5.25亿元,净利润同比增3057.05%